Your session is about to expire
← Back to Search
CLEan Trial Summary
This trial is testing a new drug for lupus to see if it is effective and safe.
- Cutaneous Lupus Erythematosus
CLEan Trial Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowCLEan Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CLEan Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
At how many hospitals or research centers is this experiment taking place?
"GNP Research-Site Number:8400008 in Cooper City, Florida, Millennium Clinical Trials-Site Number:8400001 in Thousand Oaks, California, DJL Clinical Research, PLLC-Site Number:8400003 in Charlotte, North Carolina, Californty, Florida, Millennium Clinical Trials-Site Number:8400001 in Thousand Oaks, California, DJL Clinical Research, PLLC-Site Number:8400003 in Charlotte, North Carolina are some of the locations where this trial is taking place. There are also 13 other sites across the country."
How can I qualify to participate in this clinical trial?
"The medical trial, which was originally advertised on April 1st 2021, is still searching for patients according to the listing on clinicaltrials.gov."
Are patients who are over 25 years old welcomed in this clinical trial?
"The age range for potential participants in this trial is 18 to 80 years old."
Are there certain restrictions for who is eligible to participate in this clinical trial?
"Libman-Sacks disease is the primary inclusion criteria for this trial. Between 18 to 80 years old, around 88 participants are needed for the study."
Could you explain SAR443122's impact on patients' safety?
"While there is data backing SAR443122's safety, as this is only a Phase 2 trial, there isn't enough evidence yet to suggest that it is an effective medication."
How many patients are included in this clinical trial at maximum capacity?
"In order for this study to commence, 88 patients must meet the listed inclusion criteria. The trial will be conducted by sponsor Sanofi at different locations, two of which are GNP Research-Site Number:8400008 in Cooper City, Florida and Millennium Clinical Trials-Site Number:8400001 in Thousand Oaks, California, Florida and Millennium Clinical Trials-Site Number:8400001 in Thousand Oaks, California."
Share this study with friends
Copy Link
Messenger